Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 30 | 2023 | 493 | 7.870 |
Why?
|
Head and Neck Neoplasms | 61 | 2024 | 2931 | 5.960 |
Why?
|
Free Tissue Flaps | 18 | 2024 | 335 | 4.330 |
Why?
|
Laryngectomy | 13 | 2023 | 245 | 3.490 |
Why?
|
Carcinoma, Squamous Cell | 38 | 2023 | 4058 | 3.470 |
Why?
|
Thyroidectomy | 13 | 2023 | 913 | 3.330 |
Why?
|
Papillomavirus Infections | 21 | 2024 | 1640 | 2.780 |
Why?
|
Neck | 15 | 2023 | 736 | 2.660 |
Why?
|
Robotics | 14 | 2017 | 812 | 2.650 |
Why?
|
Surgical Flaps | 15 | 2021 | 1682 | 2.480 |
Why?
|
Parotid Neoplasms | 5 | 2024 | 158 | 2.450 |
Why?
|
Neck Dissection | 11 | 2023 | 201 | 2.390 |
Why?
|
Natural Orifice Endoscopic Surgery | 8 | 2021 | 119 | 2.300 |
Why?
|
Pharyngeal Diseases | 4 | 2019 | 134 | 1.790 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 7 | 2021 | 325 | 1.740 |
Why?
|
Tongue Neoplasms | 7 | 2023 | 186 | 1.650 |
Why?
|
Papillomaviridae | 14 | 2024 | 1140 | 1.610 |
Why?
|
Otolaryngology | 6 | 2018 | 699 | 1.600 |
Why?
|
Microsurgery | 5 | 2018 | 800 | 1.480 |
Why?
|
Deglutition Disorders | 7 | 2023 | 640 | 1.450 |
Why?
|
Mouth | 10 | 2021 | 383 | 1.410 |
Why?
|
Pharyngectomy | 4 | 2016 | 45 | 1.350 |
Why?
|
Head | 7 | 2022 | 926 | 1.270 |
Why?
|
Parotid Gland | 4 | 2024 | 178 | 1.240 |
Why?
|
Endoscopy | 7 | 2021 | 1854 | 1.230 |
Why?
|
Surgery, Oral | 3 | 2014 | 133 | 1.100 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 514 | 1.070 |
Why?
|
Postoperative Complications | 28 | 2024 | 15832 | 1.060 |
Why?
|
Alphapapillomavirus | 6 | 2022 | 219 | 1.060 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2023 | 243 | 0.970 |
Why?
|
Facial Nerve | 2 | 2024 | 277 | 0.900 |
Why?
|
Oral Surgical Procedures | 4 | 2021 | 172 | 0.890 |
Why?
|
Fibula | 5 | 2024 | 270 | 0.830 |
Why?
|
Cutaneous Fistula | 2 | 2013 | 79 | 0.820 |
Why?
|
Parathyroidectomy | 2 | 2020 | 244 | 0.740 |
Why?
|
Pharynx | 2 | 2014 | 436 | 0.740 |
Why?
|
Nasal Septum | 3 | 2006 | 131 | 0.700 |
Why?
|
Airway Obstruction | 2 | 2018 | 672 | 0.700 |
Why?
|
Rhytidoplasty | 1 | 2021 | 72 | 0.700 |
Why?
|
Nose Neoplasms | 2 | 2021 | 250 | 0.680 |
Why?
|
Education | 2 | 2013 | 533 | 0.670 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.660 |
Why?
|
Computer-Assisted Instruction | 2 | 2013 | 366 | 0.650 |
Why?
|
Larynx, Artificial | 3 | 2017 | 70 | 0.640 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 597 | 0.640 |
Why?
|
Speech Disorders | 2 | 2021 | 179 | 0.630 |
Why?
|
Anastomosis, Surgical | 3 | 2017 | 991 | 0.620 |
Why?
|
Humans | 163 | 2024 | 768166 | 0.620 |
Why?
|
Parathyroid Glands | 2 | 2018 | 522 | 0.620 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1506 | 0.620 |
Why?
|
Leeching | 1 | 2018 | 6 | 0.610 |
Why?
|
Deglutition | 3 | 2022 | 208 | 0.610 |
Why?
|
Patient Care Planning | 2 | 2021 | 905 | 0.600 |
Why?
|
Surgery, Computer-Assisted | 3 | 2014 | 1003 | 0.600 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.600 |
Why?
|
Glossectomy | 3 | 2023 | 60 | 0.580 |
Why?
|
Tongue | 8 | 2023 | 406 | 0.570 |
Why?
|
Tracheostomy | 4 | 2023 | 430 | 0.570 |
Why?
|
Comprehension | 1 | 2023 | 638 | 0.570 |
Why?
|
Arteries | 4 | 2022 | 1127 | 0.560 |
Why?
|
Thyroid Diseases | 2 | 2017 | 385 | 0.560 |
Why?
|
Radiation Oncology | 1 | 2023 | 572 | 0.550 |
Why?
|
Scapula | 1 | 2018 | 175 | 0.540 |
Why?
|
Hyperemia | 1 | 2018 | 224 | 0.540 |
Why?
|
Pharyngeal Neoplasms | 2 | 2014 | 113 | 0.530 |
Why?
|
Postoperative Care | 3 | 2017 | 1480 | 0.520 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2007 | 86 | 0.520 |
Why?
|
Retrospective Studies | 48 | 2024 | 81762 | 0.500 |
Why?
|
Temporal Bone | 2 | 2024 | 683 | 0.500 |
Why?
|
Antithrombins | 1 | 2018 | 294 | 0.480 |
Why?
|
Skin Transplantation | 2 | 2018 | 1096 | 0.480 |
Why?
|
Middle Aged | 73 | 2024 | 223492 | 0.480 |
Why?
|
Salvage Therapy | 7 | 2018 | 1273 | 0.470 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1765 | 0.460 |
Why?
|
Jugular Veins | 1 | 2015 | 211 | 0.460 |
Why?
|
Hypopharynx | 2 | 2019 | 53 | 0.450 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.440 |
Why?
|
Endoscopes | 1 | 2014 | 169 | 0.440 |
Why?
|
Male | 88 | 2024 | 364719 | 0.420 |
Why?
|
Laser Therapy | 2 | 2012 | 1107 | 0.410 |
Why?
|
Thyroid Neoplasms | 4 | 2023 | 2360 | 0.410 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2023 | 290 | 0.400 |
Why?
|
Neoplasm Staging | 18 | 2024 | 11244 | 0.390 |
Why?
|
Graft Survival | 5 | 2018 | 3887 | 0.390 |
Why?
|
Cadaver | 6 | 2019 | 1363 | 0.390 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 437 | 0.390 |
Why?
|
Skull Base | 1 | 2014 | 294 | 0.380 |
Why?
|
Tonsillectomy | 3 | 2016 | 281 | 0.380 |
Why?
|
Tonsillar Neoplasms | 1 | 2011 | 50 | 0.380 |
Why?
|
Female | 81 | 2024 | 397192 | 0.380 |
Why?
|
Nasopharynx | 1 | 2014 | 420 | 0.370 |
Why?
|
Human papillomavirus 16 | 4 | 2017 | 268 | 0.370 |
Why?
|
Carcinoma | 4 | 2016 | 2332 | 0.360 |
Why?
|
Dissection | 3 | 2024 | 299 | 0.360 |
Why?
|
Salivary Glands | 1 | 2012 | 231 | 0.360 |
Why?
|
Aged | 51 | 2024 | 171504 | 0.350 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1359 | 0.350 |
Why?
|
Internship and Residency | 4 | 2018 | 5953 | 0.350 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 83 | 0.340 |
Why?
|
DNA, Viral | 9 | 2024 | 2204 | 0.340 |
Why?
|
Tracheal Stenosis | 1 | 2012 | 228 | 0.330 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1798 | 0.330 |
Why?
|
Laryngoscopy | 3 | 2011 | 714 | 0.330 |
Why?
|
Equipment Failure | 1 | 2012 | 585 | 0.330 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2021 | 9419 | 0.330 |
Why?
|
Adenoma, Pleomorphic | 2 | 2024 | 77 | 0.320 |
Why?
|
Feasibility Studies | 6 | 2020 | 5315 | 0.320 |
Why?
|
Epistaxis | 2 | 2007 | 117 | 0.310 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8542 | 0.310 |
Why?
|
Tongue Diseases | 1 | 2009 | 69 | 0.310 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 358 | 0.310 |
Why?
|
Length of Stay | 10 | 2021 | 6498 | 0.310 |
Why?
|
Clinical Competence | 5 | 2018 | 4858 | 0.300 |
Why?
|
Hospital Costs | 1 | 2014 | 957 | 0.300 |
Why?
|
Device Removal | 2 | 2017 | 643 | 0.300 |
Why?
|
Adult | 46 | 2024 | 223646 | 0.300 |
Why?
|
Education, Medical, Undergraduate | 1 | 2017 | 1085 | 0.290 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2009 | 94 | 0.290 |
Why?
|
Epiglottis | 2 | 2017 | 81 | 0.280 |
Why?
|
Enteral Nutrition | 2 | 2016 | 802 | 0.280 |
Why?
|
Surgical Wound Infection | 4 | 2022 | 1546 | 0.270 |
Why?
|
Dysphonia | 1 | 2009 | 144 | 0.260 |
Why?
|
Cicatrix | 2 | 2023 | 798 | 0.260 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2015 | 459 | 0.260 |
Why?
|
Peptide Fragments | 1 | 2018 | 5151 | 0.240 |
Why?
|
Laparoscopy | 1 | 2017 | 2041 | 0.240 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 141 | 0.240 |
Why?
|
Curriculum | 2 | 2016 | 3782 | 0.240 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2016 | 798 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3837 | 0.230 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2914 | 0.230 |
Why?
|
Treatment Outcome | 20 | 2024 | 65371 | 0.230 |
Why?
|
Hemostatics | 1 | 2007 | 246 | 0.230 |
Why?
|
Facial Nerve Diseases | 1 | 2004 | 49 | 0.220 |
Why?
|
Thyroid Gland | 4 | 2018 | 1171 | 0.220 |
Why?
|
Aged, 80 and over | 19 | 2022 | 59629 | 0.220 |
Why?
|
Growth Substances | 1 | 2005 | 759 | 0.210 |
Why?
|
Prospective Studies | 16 | 2021 | 54926 | 0.210 |
Why?
|
Risk Assessment | 10 | 2021 | 24315 | 0.210 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2004 | 131 | 0.210 |
Why?
|
Mandible | 4 | 2016 | 754 | 0.200 |
Why?
|
Patient Discharge | 2 | 2021 | 3479 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.200 |
Why?
|
Nasal Cavity | 2 | 2021 | 310 | 0.190 |
Why?
|
Cartilage | 1 | 2005 | 811 | 0.190 |
Why?
|
Joint Instability | 1 | 2009 | 803 | 0.190 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26379 | 0.190 |
Why?
|
Fistula | 2 | 2013 | 213 | 0.190 |
Why?
|
Quality of Life | 7 | 2023 | 13490 | 0.190 |
Why?
|
Weight-Bearing | 1 | 2024 | 534 | 0.180 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2784 | 0.180 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1899 | 0.180 |
Why?
|
Speech | 2 | 2023 | 557 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3721 | 0.180 |
Why?
|
Prognosis | 16 | 2021 | 30010 | 0.180 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2020 | 1791 | 0.170 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 1998 | 165 | 0.170 |
Why?
|
Hospital Mortality | 1 | 2014 | 5349 | 0.170 |
Why?
|
Chondrocytes | 1 | 2005 | 800 | 0.170 |
Why?
|
Blood-Brain Barrier | 2 | 1998 | 1034 | 0.170 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 640 | 0.170 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 594 | 0.170 |
Why?
|
Cervical Plexus | 1 | 2019 | 16 | 0.170 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 120 | 0.170 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6847 | 0.170 |
Why?
|
Models, Biological | 1 | 2015 | 9495 | 0.160 |
Why?
|
Societies, Medical | 3 | 2021 | 3968 | 0.160 |
Why?
|
Cartilage, Articular | 1 | 2006 | 1104 | 0.160 |
Why?
|
Databases as Topic | 1 | 2021 | 472 | 0.160 |
Why?
|
Gastrostomy | 3 | 2017 | 325 | 0.160 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 247 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2004 | 522 | 0.160 |
Why?
|
Maryland | 2 | 2016 | 278 | 0.150 |
Why?
|
Maxilla | 1 | 2021 | 488 | 0.150 |
Why?
|
United States | 14 | 2022 | 73039 | 0.150 |
Why?
|
Neoplasm Invasiveness | 6 | 2023 | 3620 | 0.150 |
Why?
|
Nose | 2 | 2019 | 522 | 0.150 |
Why?
|
Palate | 1 | 2018 | 126 | 0.150 |
Why?
|
Cervical Vertebrae | 1 | 2024 | 979 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.150 |
Why?
|
Lymph Nodes | 4 | 2017 | 3474 | 0.150 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1738 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 248 | 0.140 |
Why?
|
Laryngoplasty | 1 | 2017 | 53 | 0.140 |
Why?
|
Radiation Injuries | 2 | 2018 | 1198 | 0.140 |
Why?
|
Perception | 1 | 2023 | 1209 | 0.140 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 713 | 0.140 |
Why?
|
Hirudins | 1 | 2018 | 179 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2536 | 0.140 |
Why?
|
Thailand | 1 | 2017 | 288 | 0.140 |
Why?
|
Survival Analysis | 6 | 2016 | 10101 | 0.130 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11095 | 0.130 |
Why?
|
Equipment Design | 2 | 2017 | 3522 | 0.130 |
Why?
|
Clavicle | 1 | 2018 | 224 | 0.130 |
Why?
|
Reoperation | 6 | 2018 | 4329 | 0.130 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2016 | 102 | 0.130 |
Why?
|
North America | 2 | 2017 | 1289 | 0.130 |
Why?
|
Accessory Nerve | 1 | 2015 | 11 | 0.130 |
Why?
|
Credentialing | 1 | 2016 | 114 | 0.130 |
Why?
|
Cohort Studies | 9 | 2024 | 41754 | 0.130 |
Why?
|
Forearm | 2 | 2023 | 427 | 0.120 |
Why?
|
Hospitals, University | 1 | 2017 | 570 | 0.120 |
Why?
|
Case-Control Studies | 6 | 2023 | 22291 | 0.120 |
Why?
|
Swine | 3 | 2015 | 5995 | 0.120 |
Why?
|
Speech Intelligibility | 1 | 2015 | 80 | 0.120 |
Why?
|
Republic of Korea | 1 | 2017 | 591 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 463 | 0.120 |
Why?
|
Chickens | 1 | 2017 | 845 | 0.120 |
Why?
|
DNA, Neoplasm | 3 | 2015 | 1744 | 0.120 |
Why?
|
SEER Program | 3 | 2020 | 1444 | 0.120 |
Why?
|
Intubation, Gastrointestinal | 1 | 2016 | 166 | 0.120 |
Why?
|
Axilla | 1 | 2017 | 623 | 0.120 |
Why?
|
Learning Curve | 2 | 2018 | 232 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 216 | 0.120 |
Why?
|
Video-Assisted Surgery | 1 | 2014 | 51 | 0.110 |
Why?
|
Incidence | 7 | 2019 | 21538 | 0.110 |
Why?
|
Surgical Instruments | 1 | 2017 | 381 | 0.110 |
Why?
|
Periosteum | 1 | 2015 | 139 | 0.110 |
Why?
|
Time Factors | 7 | 2021 | 40218 | 0.110 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.110 |
Why?
|
Models, Anatomic | 2 | 2015 | 680 | 0.110 |
Why?
|
Young Adult | 10 | 2024 | 60066 | 0.110 |
Why?
|
Adolescent | 10 | 2024 | 89169 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2017 | 326 | 0.110 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6669 | 0.110 |
Why?
|
Microvessels | 1 | 2018 | 585 | 0.110 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2013 | 20 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1995 | 394 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12077 | 0.110 |
Why?
|
Finite Element Analysis | 1 | 2015 | 441 | 0.110 |
Why?
|
Adenoma | 1 | 2004 | 2159 | 0.110 |
Why?
|
Glycosaminoglycans | 2 | 2006 | 611 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2011 | 6229 | 0.100 |
Why?
|
Carbolines | 1 | 2015 | 295 | 0.100 |
Why?
|
Salivation | 1 | 2012 | 22 | 0.100 |
Why?
|
Esthetics | 1 | 2014 | 328 | 0.100 |
Why?
|
Hashimoto Disease | 1 | 2013 | 108 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2055 | 0.100 |
Why?
|
Skull Base Neoplasms | 1 | 2016 | 279 | 0.100 |
Why?
|
Salivary Gland Neoplasms | 1 | 2016 | 306 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2661 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3556 | 0.100 |
Why?
|
Dehydration | 1 | 2013 | 216 | 0.100 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 43 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2014 | 39348 | 0.090 |
Why?
|
Time and Motion Studies | 1 | 2011 | 143 | 0.090 |
Why?
|
Baltimore | 1 | 2011 | 233 | 0.090 |
Why?
|
In Situ Hybridization | 4 | 2016 | 1903 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3110 | 0.090 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2011 | 99 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1676 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 853 | 0.090 |
Why?
|
Surgical Staplers | 1 | 2010 | 34 | 0.090 |
Why?
|
Radial Artery | 1 | 2011 | 188 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2176 | 0.080 |
Why?
|
Thyroid Nodule | 1 | 2017 | 767 | 0.080 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 419 | 0.080 |
Why?
|
Risk Factors | 9 | 2022 | 74944 | 0.080 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12543 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1110 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.080 |
Why?
|
Phantoms, Imaging | 2 | 2015 | 2512 | 0.080 |
Why?
|
Intraoperative Period | 1 | 2010 | 513 | 0.080 |
Why?
|
Radiotherapy | 2 | 2021 | 1502 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7454 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1835 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1523 | 0.080 |
Why?
|
Stroboscopy | 1 | 2009 | 62 | 0.080 |
Why?
|
Linear Models | 2 | 2020 | 5884 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1561 | 0.080 |
Why?
|
Cysts | 1 | 2014 | 685 | 0.080 |
Why?
|
Bone Transplantation | 1 | 2013 | 925 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3488 | 0.080 |
Why?
|
Papilloma | 1 | 2009 | 143 | 0.080 |
Why?
|
Regression Analysis | 2 | 2017 | 6340 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 793 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6514 | 0.070 |
Why?
|
Radiopharmaceuticals | 2 | 2016 | 2735 | 0.070 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 173 | 0.070 |
Why?
|
Voice Quality | 1 | 2009 | 226 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 1998 | 4568 | 0.070 |
Why?
|
Sarcoma | 1 | 2018 | 1806 | 0.070 |
Why?
|
Endopeptidase K | 1 | 2006 | 23 | 0.070 |
Why?
|
Pain Measurement | 1 | 2017 | 3583 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20760 | 0.070 |
Why?
|
Postoperative Period | 3 | 2018 | 1826 | 0.070 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2011 | 452 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2017 | 3800 | 0.070 |
Why?
|
Osmotic Pressure | 2 | 1998 | 137 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 6004 | 0.070 |
Why?
|
Program Development | 1 | 2012 | 1300 | 0.060 |
Why?
|
Voice Disorders | 1 | 2009 | 286 | 0.060 |
Why?
|
Compressive Strength | 1 | 2006 | 159 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2420 | 0.060 |
Why?
|
Tissue Engineering | 2 | 2006 | 1893 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2016 | 2235 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13290 | 0.060 |
Why?
|
Hydrolysis | 1 | 2006 | 646 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3216 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2381 | 0.060 |
Why?
|
Animals | 8 | 2017 | 169246 | 0.060 |
Why?
|
Graft Rejection | 2 | 2018 | 4492 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2009 | 942 | 0.060 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15454 | 0.060 |
Why?
|
Tensile Strength | 1 | 2005 | 332 | 0.060 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 571 | 0.060 |
Why?
|
Early Ambulation | 1 | 2024 | 49 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8741 | 0.060 |
Why?
|
Voice | 1 | 2007 | 268 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2479 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3706 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2954 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2012 | 1967 | 0.060 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 344 | 0.050 |
Why?
|
Biopsy | 2 | 2014 | 6793 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5863 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2005 | 590 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8054 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3436 | 0.050 |
Why?
|
Patient Readmission | 2 | 2016 | 3288 | 0.050 |
Why?
|
Anisotropy | 1 | 2006 | 1292 | 0.050 |
Why?
|
Antisepsis | 1 | 2022 | 16 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 710 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4598 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5706 | 0.050 |
Why?
|
Comorbidity | 2 | 2014 | 10590 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 311 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2434 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 336 | 0.050 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1402 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 638 | 0.050 |
Why?
|
Patient Positioning | 1 | 2024 | 332 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4428 | 0.040 |
Why?
|
Oropharynx | 1 | 2021 | 139 | 0.040 |
Why?
|
Enzyme Induction | 2 | 1998 | 455 | 0.040 |
Why?
|
Child | 6 | 2024 | 80917 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3239 | 0.040 |
Why?
|
Neuroglia | 2 | 1996 | 960 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 845 | 0.040 |
Why?
|
Radius | 1 | 2023 | 443 | 0.040 |
Why?
|
Sex Distribution | 2 | 2016 | 2278 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Temperature | 1 | 2006 | 2234 | 0.040 |
Why?
|
Databases, Factual | 2 | 2014 | 8080 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2846 | 0.040 |
Why?
|
Sural Nerve | 1 | 2019 | 105 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2873 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12840 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9538 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6283 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2024 | 1443 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 18065 | 0.040 |
Why?
|
Collagen | 1 | 2006 | 2643 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4887 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 63 | 0.040 |
Why?
|
Nerve Transfer | 1 | 2019 | 132 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 1942 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1996 | 0.040 |
Why?
|
Software | 1 | 2011 | 4478 | 0.040 |
Why?
|
Sex Factors | 3 | 2017 | 10632 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1998 | 8128 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 110 | 0.030 |
Why?
|
Perioperative Care | 1 | 2024 | 1043 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1998 | 2474 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 9015 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 30238 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6526 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 1998 | 364 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18412 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3929 | 0.030 |
Why?
|
Mannitol | 1 | 1995 | 176 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2017 | 342 | 0.030 |
Why?
|
Fixatives | 1 | 2015 | 90 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 32 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 139 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 757 | 0.030 |
Why?
|
Immunoblotting | 1 | 1998 | 1647 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10840 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 213 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4310 | 0.030 |
Why?
|
Amines | 1 | 2016 | 280 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6329 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 307 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 246 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 596 | 0.030 |
Why?
|
Formaldehyde | 1 | 2015 | 362 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 196 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18349 | 0.030 |
Why?
|
Ear Auricle | 1 | 2012 | 31 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 1703 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 549 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2923 | 0.030 |
Why?
|
Esophagectomy | 1 | 2016 | 481 | 0.030 |
Why?
|
Rats | 3 | 1998 | 23760 | 0.020 |
Why?
|
Radiotherapy, High-Energy | 1 | 2012 | 228 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1141 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 128 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 914 | 0.020 |
Why?
|
Seroma | 1 | 2011 | 75 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.020 |
Why?
|
Metagenome | 1 | 2014 | 465 | 0.020 |
Why?
|
Hypocalcemia | 1 | 2011 | 205 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1015 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 19015 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 1141 | 0.020 |
Why?
|
Preoperative Period | 1 | 2011 | 565 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7214 | 0.020 |
Why?
|
Thigh | 1 | 2010 | 238 | 0.020 |
Why?
|
Analgesics | 1 | 2016 | 1071 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1407 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 1135 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20227 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42669 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2011 | 275 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15869 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1758 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2430 | 0.020 |
Why?
|
Smoking | 2 | 2014 | 9092 | 0.020 |
Why?
|
Vocal Cords | 1 | 2011 | 520 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 766 | 0.020 |
Why?
|
Face | 1 | 2012 | 1029 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2048 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2982 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4580 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13671 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2744 | 0.020 |
Why?
|
Radiology | 1 | 2019 | 2104 | 0.020 |
Why?
|
Brain Injuries | 1 | 1996 | 2057 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2013 | 3160 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2715 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4912 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1208 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2125 | 0.010 |
Why?
|
Blood Pressure | 2 | 1996 | 8543 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 7598 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7477 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5902 | 0.010 |
Why?
|
Fees, Medical | 1 | 2002 | 111 | 0.010 |
Why?
|
Ligation | 1 | 2002 | 446 | 0.010 |
Why?
|
Wound Healing | 1 | 2011 | 2809 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12800 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5330 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4648 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9263 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5926 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5792 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10266 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16726 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1667 | 0.010 |
Why?
|
Neurons | 1 | 1995 | 9514 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1996 | 563 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13014 | 0.010 |
Why?
|
Oligodendroglia | 1 | 1996 | 540 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 14164 | 0.010 |
Why?
|
Brain | 1 | 1996 | 27360 | 0.010 |
Why?
|
Cerebellum | 1 | 1996 | 1522 | 0.010 |
Why?
|
Astrocytes | 1 | 1996 | 1350 | 0.000 |
Why?
|
Microglia | 1 | 1996 | 1376 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5812 | 0.000 |
Why?
|